Sign inJoin
Company / Finance

Becton, Dickinson and Company

BDX · NYSE

Becton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.

FollowAdd to WatchlistAsk Question
NYSEBDXCoverage BootstrapBecton, Dickinson and Company
Latest ReportMay 19, 2026BD: the medtech reset has to turn hospital scale back into cleaner earningsView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 company reports
Latest Thesis

BD: the medtech reset has to turn hospital scale back into cleaner earnings

Becton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.

May 19, 2026Research reportSlides available
Read reportOpen slidesDiscussion (0)
Becton, Dickinson and Companythe medtech reset has to turn hospital scale back into cleaner eMay 19, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
BD: the medtech reset has to turn hospital scale back into cleaner earningsBecton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.NYSEMay 19, 2026Research reportReadSlides